Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma.
- Resource Type
- Article
- Source
- FEBS Open Bio; Aug2021, Vol. 11 Issue 8, p2186-2197, 12p
- Subject
CANCER stem cells PAPILLARY carcinoma THYROID cancer SURVIVAL rate EPITHELIAL-mesenchymal transition THYROID gland - Language
- ISSN
- 22115463